Repeated Administration of Centhaquin to Pregnant Rats did not Affect Postnatal Development and Expression of Endothelin Receptors in the Brain, Heart or Kidney of Pups

Abstract

The effect of repeated administration of centhaquin to pregnant rats on postnatal development, and expression of ET_A and ET_B receptors was determined. Pregnant rats were treated daily with either saline or centhaquin for 2 weeks. Male rat pups were sacrificed on day 1, 7, 14 and 28 of birth. Brain, kidney and heart were removed to study the expression of ET_A and ET_B receptor protein levels. Body weight of pregnant rats increased steadily in both vehicle and centhaquin groups. Expression of ET_A receptors in the heart and kidney was similar in vehicle and centhaquin treated postpartum rats, but was significantly increased in the brain of centhaquin treated postpartum rats. No change in expression of ET_B receptors was observed. In postnatal rats, mean body weight and weights of the brain, kidney and heart increased proportionally with advancing age and were similar in vehicle and centhaquin groups. The expression of ET_A receptors in the brain, heart and kidneys was similar in vehicle and centhaquin groups. ET_B receptor expression significantly (p<0.001) decreased by 72% and 70% on day 28 compared to rats of age 1, 7 and 14 days in control and centhaquin groups, respectively. Centhaquin treated rats showed similar expression of ET_A and ET_B receptors compared to vehicle treatment. This study suggests that repeated administration of centhaquin was well tolerated by pregnant rats that gave birth to normal pups. Centhaquin did not affect postnatal development of rats and had similar expression of ET_A and ET_B receptors compared to control pups.

Key words

endothelin - centhaquin - postnatal development - central nervous system - ET_A receptors - ET_B receptors

• References

• 1 Srimal RC, Mason DFJ, Dhawan BN. Studies on 2-(2-(4-(3-methyl­phenyl)1-piperazinyl)ethyl quinoline (centhaquine), a centrally acting antihypertensive II. Effect of cardiohemodynamics. Asia Pac J Pharmacol 1990; 5: 185-190
• 2 Gulati A, Hussain G, Srimal RC. Effect of repeated administration of centhaquin, a centrally acting hypotensive drug, on adrenergic, cholinergic (muscarinic), dopaminergic, and serotonergic receptors in brain-regions of rat. Drug Develop Res 1991; 23: 307-323
• 3 Srimal RC, Gulati K, Nityanand S et al. Pharmacological studies on 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl) quinoline (centhaquin). I. Hypotensive activity. Pharmacol Res 1990; 22: 319-329
• 4 Gulati A, Lavhale MS, Garcia DJ et al. Centhaquin improves resuscitative effect of hypertonic saline in hemorrhaged rats. J Surg Res 2012; 178: 415-423
• 5 Andurkar SV, Gulati A. Assessment of the analgesic effect of centhaquin in mouse tail flick and hot-plate tests. Pharmacology 2011; 88: 233-241
• 6 Sharma AC, Gulati A. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995; 23: 874-884
• 7 Timmermans PB, Van Zwieten PA. Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur J Pharmacol 1980; 63: 199-202
• 8 Yoo KH, Yim HE, Jang GY et al. Endothelin A receptor blockade influences apoptosis and cellular proliferation in the developing rat kidney. J Korean Med Sci 2009; 24: 138-145
• 9 Kurihara Y, Kurihara H, Suzuki H et al Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994; 368: 307-310
• 10 Kurihara Y, Kurihara H, Oda H et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. J Clin Invest 1995; 96: 293-300
• 11 Brand M, Le Moullec JM, Corvol P et al. Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo. J Clin Invest 1998; 101: 549-559
• 12 Gulati A, Kumar A, Morrison S et al. Effect of centrally administered endothelin agonists on systemic and regional blood circulation in the rat: role of sympathetic nervous system. Neuropeptides 1997; 31: 301-309
• 13 Gulati A, Rebello S, Kumar A. Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats. Am J Physiol 1997; 273: 1177-1186
• 14 Souza HC, Terzini GC, da Silva VJ et al. Increased cardiac sympathetic drive and reduced vagal modulation following endothelin receptor antagonism in healthy conscious rats. Clin Exp Pharmacol Physiol 2008; 35: 751-756
• 15 Gulati A. Evidence for antagonistic activity of endothelin for clonidine induced hypotension and bradycardia. Life Sci 1992; 50: 153-160
• 16 Gulati A, Srimal RC. Endothelin antagonizes the hypotension and potentiates the hypertension induced by clonidine. Eur J Pharmacol 1993; 230: 293-300
• 17 Lavhale MS, Briyal S, Parikh N et al. Endothelin modulates the cardiovascular effects of clonidine in the rat. Pharmacol Res 2010; 62: 489-499
• 18 D’Angelo G, Pollock JS, Pollock DM. In vivo evidence for endothelin-1-mediated attenuation of alpha1-adrenergic stimulation. Am J Physiol Heart Circ Physiol 2006; 290: 1251-1258
• 19 Vazquez-Prado J, Medina LC, Garcia-Sainz JA. Activation of endothelin ETA receptors induces phosphorylation of alpha1b-adrenoreceptors in Rat-1 fibroblasts. J Biol Chem 1997; 272: 27330-27337
• 20 Gulati A, Arora RC, Crayton J. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin. Eur J Pharmacol 1993; 231: 151-156
• 21 Briyal S, Philip T, Gulati A. Endothelin-A Receptor Antagonists Prevent Amyloid-beta-Induced Increase in ETA Receptor Expression, Oxidative Stress, and Cognitive Impairment. J Alzheimers Dis 2011; 23: 491-503
• 22 Leonard MG, Briyal S, Gulati A. Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats. Brain Res 2011; 1420: 48-58
• 23 Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 267-275
• 24 Gulati A, Bhalla S, Matwyshyn G et al. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874. Pharmacology 2009; 83: 45-58
• 25 Pla P, Larue L. Involvement of endothelin receptors in normal and pathological development of neural crest cells. Int J Dev Biol 2003; 47: 315-325
• 26 Heanue TA, Pachnis V. Enteric nervous system development and Hirschsprung’s disease: advances in genetic and stem cell studies. Nat Rev Neurosci 2007; 8: 466-479
• 27 Leonard MG, Briyal S, Gulati A. Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats. Brain Res 2012; 1464: 14-23
• 28 Chuquet J, Benchenane K, Toutain J et al. Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat. Stroke 2002; 33: 3019-3025
• 29 Quinn R. Comparing rat’s to human’s age: how old is my rat in people years?. Nutrition 2005; 21: 775-777